Yield10 Bioscience, Inc.
News
Yield10 Bioscience Announces Second Quarter 2024 Financial Results
Globe Newswire WOBURN, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today reported financial results for the...\n more…
Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets
Globe Newswire - Nufarm to pay up to USD $5 million in consideration for the license-The parties will negotiate the sale of essentially all of Yield10's assets to Nufarm WOBURN, Mass. and WEST SACRAMENTO, Calif...\n more…
Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina
Globe Newswire Engineered Camelina is intended to enable the land-based production of omega-3 oils used in aquafeed, petfood and human nutritionWOBURN, Mass. and HARPENDEN, United Kingdom, June 17, 2024 (GLOBE...\n more…
Yield10 Bioscience Announces Addition of Camelina to INTERLINE Herbicide Label
Globe Newswire - EPA approved an amendment to the label of INTERLINE herbicideto include Camelina -The supplemental label now allows application of INTERLINE for over-the-top weed control in Camelina WOBURN...\n more…
YTEN Stock Earnings: Yield10 Bioscience Misses EPS, Misses Revenue for Q1 2024
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nYTEN stock results show that Yield10 Bioscience missed analyst estimates for earnings per share and missed on revenue for the first...\n more…
